McBride John S.

Avg. Two Year Performance

No purchase track record
96% Avg. Sale Return
40% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return14%22%48%78%96%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2

Eledon Pharmaceuticals, Inc.

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--